Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Profit After Tax (2017 - 2020)

enVVeno Medical has reported Profit After Tax over the past 4 years, most recently at -$4.4 million for Q4 2020.

  • For Q4 2020, Profit After Tax fell 90.94% year-over-year to -$4.4 million; the TTM value through Dec 2020 reached -$9.1 million, down 19.8%, while the annual FY2025 figure was -$19.5 million, 10.76% up from the prior year.
  • Profit After Tax for Q4 2020 was -$4.4 million at enVVeno Medical, down from -$2.0 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$1.2 million in Q1 2020 and troughed at -$5.0 million in Q2 2018.
  • A 4-year average of -$2.4 million and a median of -$1.9 million in 2019 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: crashed 303.98% in 2018 and later skyrocketed 66.85% in 2019.
  • Year by year, Profit After Tax stood at -$3.1 million in 2017, then skyrocketed by 42.97% to -$1.8 million in 2018, then decreased by 28.58% to -$2.3 million in 2019, then tumbled by 90.94% to -$4.4 million in 2020.
  • Business Quant data shows Profit After Tax for NVNO at -$4.4 million in Q4 2020, -$2.0 million in Q3 2020, and -$1.6 million in Q2 2020.